Literature DB >> 34520787

Cannabis vaping among adults in the United States: Prevalence, trends, and association with high-risk behaviors and adverse respiratory conditions.

Ellen Boakye1, Olufunmilayo H Obisesan2, S M Iftekhar Uddin3, Omar El-Shahawy4, Omar Dzaye5, Albert D Osei6, Emelia J Benjamin7, Andrew C Stokes8, Rose Marie Robertson9, Aruni Bhatnagar10, Michael J Blaha11.   

Abstract

The e-cigarette or vaping product-use-associated lung injury outbreak in the United States has raised concerns about the potential health effects of cannabis vaping, a method of cannabis use that is becoming increasingly popular. We used 2017-2019 Behavioral Risk Factor Surveillance System data to estimate yearly prevalence and trends of past-30-day cannabis use and vaping among US adults. We used multivariable logistic regression to evaluate the associations of cannabis vaping with high-risk behaviors, asthma, and other respiratory symptoms. Our sample size was 160,209 (53,945-2017; 55,475-2018; and 50,789-2019). Past-30-day cannabis use prevalence increased from 10.0% (95% CI, 9.4%-10.7%) in 2017 to 13.4% (12.8%-12.0%) in 2019. Similarly, past-30-day cannabis vaping prevalence increased from 1.0% (0.8%-1.2%) to 2.0% (1.7%-2.2%) over the same period, with the greatest increase, 1.2% to 3.9%, observed among young adults (18-24 years). Individuals who vaped cannabis were more likely to concurrently vape nicotine. Cannabis vaping was associated with increased odds of heavy alcohol use (aOR, 1.95; 95% CI, 1.45-2.63), binge drinking (aOR, 2.82; 95% CI, 2.25-3.54), and other high-risk behaviors (aOR, 2.47; 95% CI, 1.89-3.24). In analyses adjusting for sociodemographic characteristics and body mass index, cannabis vaping was not associated with asthma (aOR, 1.03; 95% CI, 0.64-1.64) or other respiratory symptoms (aOR, 1.08; 95% CI, 0.44-2.63). Adjusting for nicotine vaping did not substantively alter these associations. The prevalence of past-30-day cannabis vaping has increased, particularly among young adults, and was associated with high-risk behaviors. Although there was no association between cannabis vaping and asthma or other respiratory symptoms, the increasing trends of cannabis vaping, particularly among young adults, raise concern and underscore the need for continued surveillance.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Cannabis; High-risk behaviors; Respiratory symptoms; Trends; Vaping

Mesh:

Year:  2021        PMID: 34520787     DOI: 10.1016/j.ypmed.2021.106800

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.637


  2 in total

1.  A Comparison of Vaping Behavior, Perceptions, and Dependence among Individuals Who Vape Nicotine, Cannabis, or Both.

Authors:  Savreen K Saran; Kalin Z Salinas; Jonathan Foulds; Övgϋ Kaynak; Brianna Hoglen; Kenneth R Houser; Nicolle M Krebs; Jessica M Yingst; Sophia I Allen; Candace R Bordner; Andrea L Hobkirk
Journal:  Int J Environ Res Public Health       Date:  2022-08-20       Impact factor: 4.614

2.  The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury.

Authors:  Ellen Boakye; Omar El Shahawy; Olufunmilayo Obisesan; Omar Dzaye; Albert D Osei; John Erhabor; S M Iftekhar Uddin; Michael J Blaha
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.